|
Name |
Methyl 3-oxoheptanoate
|
Molecular Formula | C8H14O3 | |
IUPAC Name* |
methyl 3-oxoheptanoate
|
|
SMILES |
CCCCC(=O)CC(=O)OC
|
|
InChI |
InChI=1S/C8H14O3/c1-3-4-5-7(9)6-8(10)11-2/h3-6H2,1-2H3
|
|
InChIKey |
CZTKGERSDUGZPQ-UHFFFAOYSA-N
|
|
Synonyms |
Methyl 3-oxoheptanoate; 39815-78-6; Methyl valerylacetate; Heptanoic acid, 3-oxo-, methyl ester; 3-Oxoenanthic Acid Methyl Ester; Methyl 3-Oxoenanthate; 3-Oxoheptanoic Acid Methyl Ester; 3-Ketoheptanoic Acid Methyl Ester; METHYL3-OXOHEPTANOATE; Heptansaure-methylester; Methyl Valeric Acetate; methyl-3-oxoheptanoate; Methyl?Valeric?Acetate; Methyl 3-oxoheptanoate #; SCHEMBL662653; 3-Ketoenanthic acid methyl ester; 3-oxo-heptanoic acid methylester; DTXSID40338056; 3-oxo-heptanoic acid methyl ester; ZINC2556891; MFCD00191568; AKOS015855346; DS-3357; BP-10048; CS-0152392; FT-0655438; O0246; H10810; EN300-1440036; A824745; Q-201374; Methyl 3-oxoheptanoate, produced by Wacker Chemie AG, Burghausen, Germany, >=96.0% (GC)
|
|
CAS | 39815-78-6 | |
PubChem CID | 546075 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 158.19 | ALogp: | 1.3 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 43.4 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.452 |
Caco-2 Permeability: | -4.475 | MDCK Permeability: | 0.00004200 |
Pgp-inhibitor: | 0.096 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.35 |
Blood-Brain-Barrier Penetration (BBB): | 0.994 | Plasma Protein Binding (PPB): | 28.17% |
Volume Distribution (VD): | 0.477 | Fu: | 81.08% |
CYP1A2-inhibitor: | 0.204 | CYP1A2-substrate: | 0.367 |
CYP2C19-inhibitor: | 0.154 | CYP2C19-substrate: | 0.704 |
CYP2C9-inhibitor: | 0.065 | CYP2C9-substrate: | 0.481 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.233 |
CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.227 |
Clearance (CL): | 8.815 | Half-life (T1/2): | 0.931 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.043 |
Drug-inuced Liver Injury (DILI): | 0.371 | AMES Toxicity: | 0.16 |
Rat Oral Acute Toxicity: | 0.047 | Maximum Recommended Daily Dose: | 0.028 |
Skin Sensitization: | 0.729 | Carcinogencity: | 0.056 |
Eye Corrosion: | 0.99 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.793 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000235 | 0.559 | D0OL6O | 0.447 | ||||
ENC000232 | 0.515 | D0AY9Q | 0.365 | ||||
ENC001036 | 0.487 | D03ZJE | 0.294 | ||||
ENC000253 | 0.475 | D0ZI4H | 0.286 | ||||
ENC000371 | 0.472 | D0Y4AW | 0.283 | ||||
ENC001025 | 0.432 | D01QLH | 0.275 | ||||
ENC000758 | 0.415 | D0Y7ZD | 0.268 | ||||
ENC000249 | 0.413 | D0O4GY | 0.262 | ||||
ENC000234 | 0.410 | D0A7MY | 0.250 | ||||
ENC000735 | 0.405 | D0Y3KG | 0.250 |